<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://biotechmorning.com/news/harrow-tyrvaya-nasal-spray-dry-eye-acquisition</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:15:53.313Z</news:publication_date>
      <news:title>The Dry Eye Drug That Ditched Eye Drops Entirely</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/actimed-recovers-cachexia-rights-faraday-collapse</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:15:08.533Z</news:publication_date>
      <news:title>When Your Partner Goes Broke, You Take the Keys Back</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/ensoma-running-out-of-lifelines</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:14:23.027Z</news:publication_date>
      <news:title>Ensoma Is Running Out of Lifelines</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/biotech-ipo-window-blossomhill-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:13:40.988Z</news:publication_date>
      <news:title>Biotech&apos;s IPO Window Just Cracked Wide Open</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/latigo-biotherapeutics-ipo-346-million</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:12:59.450Z</news:publication_date>
      <news:title>A Pain Startup Just Raised $346M on Day One. Here&apos;s Why Wall Street Showed Up.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/icon-anthropic-claude-ai-clinical-trials</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:12:13.208Z</news:publication_date>
      <news:title>The Biggest CRO Just Handed Its Clinical Trials to an AI</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/repligen-biolife-solutions-acquisition-cell-therapy-2</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:11:31.912Z</news:publication_date>
      <news:title>Repligen Just Bet $1.5 Billion on the Plumbing of Cell Therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/supernus-indivior-merger-cns-powerhouse</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:10:49.269Z</news:publication_date>
      <news:title>Two Rivals Just Merged to Build a $2.2B Brain Drug Empire</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/eli-lilly-3-8-billion-psychedelics-atai-beckley</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:09:57.237Z</news:publication_date>
      <news:title>Eli Lilly Just Dropped $3.8 Billion on Psychedelics. Yes, Really.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/fda-approves-bemotrizinol-first-new-sunscreen-ingredient-20-years-2</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-10T14:09:13.414Z</news:publication_date>
      <news:title>America&apos;s Sunscreen Has Been Stuck Since the Late 1990s. That Just Changed.</news:title>
    </news:news>
  </url>
</urlset>